BioSig raises $810K via PIPE; sells shares and warrants to investors

On September 21, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited and institutional investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 1,458,770 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.5554 per share, and warrants (the “Warrants”) to purchase up to 729,385 shares of Common Stock (the “Warrant Shares” and together with the Shares and the Warrants, the “Securities”), at an exercise price of $0.4929 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $810,200.84 (the “September PIPE”).